» Articles » PMID: 35542417

Promising Bactericidal Approach of Dihydrazone Analogues Against Bio-film Forming Gram-negative Bacteria and Molecular Mechanistic Studies

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 11
PMID 35542417
Authors
Affiliations
Soon will be listed here.
Abstract

Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer and the efficiency of efflux pumps to pump out the drugs from the cytoplasm. The development of alternative therapeutic strategies to tackle ESCAPE Gram-negative members is of extreme necessity to provide a solution to the cause of life-threatening infections. The present investigations demonstrated that compounds 17, 20, 25 and 26 possessing the presence of electron donating (OH and OCH) groups on the phenyl rings are highly potent; whereas compounds 9, 10, 15, 16, 18, 33 and 36 showed moderate activity against Gram-negative bacteria. An excellent dose-dependent antibacterial activity was established compared to that of the standard antibiotic ampicillin. Significant anti-biofilm properties were measured quantitatively, showing optical density (O.D) values of 0.51 ± 015, 0.63 ± 0.20, 0.38 ± 0.07 and 0.62 ± 0.11 at 492 nm and the leakage of cellular components by the compounds, such as 17, 20, 25 and 26, increased the O.D. of respective treated samples compared to the control. In addition, the implication of experimental results is discussed in the light of the lack of survivability of planktonic bacteria and biofilm destruction . These results revealed the great significance of the development of a new generation of synthetic materials with greater efficacy in anti-biofilm properties by targeting to lock the bio-film associated protein Bap in Gram-negative bacteria.

Citing Articles

Synthesis, antibacterial evaluation and in silico studies of novel 2-(benzo[d]thiazol-2-yl)-N-arylacetamides and their derivatives as potential DHFR inhibitors.

Metwally N, Elgemeie G, Abdelrazek A, Eldaly S BMC Chem. 2025; 19(1):29.

PMID: 39891220 PMC: 11784096. DOI: 10.1186/s13065-025-01386-5.


Antibacterial Potential of Ethyl 3,5-Dibromoorsellinate, a Derivative of Diphenyl Ethers from , against Methicillin-Resistant .

Nguyen D, Duong T, Nguyen T, Nguyen H, Nguyen C ACS Omega. 2024; 9(50):50012-50023.

PMID: 39713661 PMC: 11656388. DOI: 10.1021/acsomega.4c09518.


A survey of isatin hybrids and their biological properties.

Shu V, Eni D, Ntie-Kang F Mol Divers. 2024; 29(2):1737-1760.

PMID: 38833124 DOI: 10.1007/s11030-024-10883-z.


A new antimicrobial PVC-based polymeric material incorporating bisacylthiourea complexes.

Hassan H, Elhusseiny A BMC Chem. 2023; 17(1):44.

PMID: 37138320 PMC: 10157947. DOI: 10.1186/s13065-023-00958-7.


Surface functionality density regulated reduction of nanosilver on hierarchial wrinkled mesoporous silica nanoparticles and their antibacterial activity.

Wan X, Wu L, Pei H, Ke H, Yang G, Tang J RSC Adv. 2022; 8(35):19420-19425.

PMID: 35540958 PMC: 9080645. DOI: 10.1039/c8ra02903b.


References
1.
Giedraitiene A, Vitkauskiene A, Naginiene R, Pavilonis A . Antibiotic resistance mechanisms of clinically important bacteria. Medicina (Kaunas). 2011; 47(3):137-46. View

2.
Andersson D, Hughes D . Antibiotic resistance and its cost: is it possible to reverse resistance?. Nat Rev Microbiol. 2010; 8(4):260-71. DOI: 10.1038/nrmicro2319. View

3.
Mace S, Truelstrup Hansen L, Rupasinghe H . Anti-Bacterial Activity of Phenolic Compounds against Streptococcus pyogenes. Medicines (Basel). 2017; 4(2). PMC: 5590061. DOI: 10.3390/medicines4020025. View

4.
Manukumar H, Chandrasekhar B, Rakesh K, Ananda A, Nandhini M, Lalitha P . Novel T-C@AgNPs mediated biocidal mechanism against biofilm associated methicillin-resistant (Bap-MRSA) 090, cytotoxicity and its molecular docking studies. Medchemcomm. 2018; 8(12):2181-2194. PMC: 6072311. DOI: 10.1039/c7md00486a. View

5.
Archer N, Mazaitis M, Costerton J, Leid J, Powers M, Shirtliff M . Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence. 2011; 2(5):445-59. PMC: 3322633. DOI: 10.4161/viru.2.5.17724. View